00000nam 2200000zi 4500 9.915290 CaOODSP 20221101123821 m o d f cr mn||||||||| 220909e202209 onc ob f000 0 eng d 9780660454047 (report) 9780660454054 (summary) CaOODSP eng rda CaOODSP n-cn--- HP40-323/2022E-PDF HP40-323/2022-1E-PDF NACI rapid response : updated interim guidance on Imvamune® in the context of ongoing monkeypox outbreaks. National Advisory Committee on Immunization rapid response : updated interim guidance on Imvamune® in the context of ongoing monkeypox outbreaks Ottawa, ON : Public Health Agency of Canada = Agence de la santé publique du Canada, September 2022. ©2022 1 online resource (27 pages) + summary (7 pages) text txt rdacontent computer c rdamedia online resource cr rdacarrier Issued also in French under title: Réponse rapide du CCNI : mise à jour des directives provisoires sur l'Imvamuneᴹᴰ dans le contexte des éclosions actuelles de variole simienne. On cover: An advisory committee statement (ACS), National Advisory Committee on Immunization (NACI). "Pub.: 220414." "Pub.: 220416." Includes bibliographical references (pages 20-23). Human monkeypox Vaccination Canada. Human monkeypox Vaccination Government policy Canada. Public Health Agency of Canada, issuing body. Canada. National Advisory Committee on Immunization, issuing body. Réponse rapide du CCNI : (CaOODSP)9.915289 PDF 1.53 MB https://publications.gc.ca/collections/collection_2022/aspc-phac/HP40-323-2022-eng.pdf (report) PDF 1.25 MB https://publications.gc.ca/collections/collection_2022/aspc-phac/HP40-323-2022-1-eng.pdf (summary) 220414 220416